(Q41175157)

27 September 2017

1 reference

title

ACE inhibitors and the kidney. A risk-benefit assessment (English)

1 reference

27 September 2017

G Navis

1

1 reference

27 September 2017

H J Faber

series ordinal

2

1 reference

27 September 2017

D de Zeeuw

series ordinal

3

1 reference

27 September 2017

P E de Jong

series ordinal

4

1 reference

27 September 2017

1 September 1996

1 reference

27 September 2017

1 reference

27 September 2017

15

1 reference

27 September 2017

3

1 reference

27 September 2017

200-211

1 reference

https://scigraph.springernature.com/pub.10.2165/00002018-199615030-00005

27 September 2017

0 references

cites work

Plasma lipids and the progression of nephropathy in diabetes mellitus type II: effect of ACE inhibitors

1 reference

12 December 2020

Is the antiproteinuric effect of ACE inhibition mediated by interference in the renin-angiotensin system?

1 reference

12 December 2020

Captopril induced reversible renal failure: a marker of renal artery stenosis affecting a solitary kidney

1 reference

12 December 2020

Renal Response to Captopril in Severe Heart Failure: Role of Furosemide in Natriuresis and Reversal of Hyponatremia

1 reference

12 December 2020

Effect of captopril on blood pressure and renal function in patients with transplant renal artery stenosis

1 reference

12 December 2020

Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study.

1 reference

12 December 2020

Hemodynamic and volume changes associated with captopril

1 reference

12 December 2020

[Renal insufficiency after administration of captopril in renal artery stenosis with a single kidney or bilateral stenosis is not compulsory]

1 reference

12 December 2020

Differential effects of enalapril and atenolol on proteinuria and renal haemodynamics in non-diabetic renal disease

1 reference

12 December 2020

Renal toxicity of the nonsteroidal anti-inflammatory drugs

1 reference

12 December 2020

Effects of captopril on arterial and venous pressure, renal function, and humoral factors in severe chronic congestive heart failure

1 reference

12 December 2020

Renal function during antihypertensive treatment

1 reference

12 December 2020

Late outcome of a controlled trial of enalapril treatment in progressive chronic renal failure. Hard end-points and influence of proteinuria

1 reference

12 December 2020

Antiproteinuric effect of blood-pressure-lowering agents: a meta-analysis of comparative trials.

1 reference

12 December 2020

Prevalence, pathogenesis, and functional significance of aldosterone deficiency in hyperkalemic patients with chronic renal insufficiency

1 reference

12 December 2020

Evolution of blockade of the renin-angiotensin system

1 reference

12 December 2020

Low-dose captopril for the treatment of mild to moderate hypertension. I. Results of a 14-week trial. Veterans Administration Cooperative Study Group on Antihypertensive Agents

1 reference

12 December 2020

ACE polymorphism does not determine short-term renal response to ACE-inhibition in proteinuric patients

1 reference

12 December 2020

Mineralocorticoid biosynthesis in patients with hyporeninemic hypoaldosteronism

1 reference

12 December 2020

Partial remission of nephrotic syndrome in patient on long-term simvastatin

1 reference

12 December 2020

Renal artery occlusion in patients with renovascular hypertension treated with captopril

1 reference

12 December 2020

Dosing of antihypertensive medications in patients with renal insufficiency

1 reference

12 December 2020

Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis

1 reference

12 December 2020

The antiproteinuric effects of blood pressure-lowering agents: differences between nondiabetics and diabetics

1 reference

12 December 2020

Glomerular mesangium: its function and relationship to angiotensin II

1 reference

12 December 2020

Glomerular preload and afterload reduction as a tool to lower urinary protein leakage: will such treatments also help to improve renal function outcome?

1 reference

12 December 2020

Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules?

1 reference

12 December 2020

Captopril-associated acute interstitial nephritis

1 reference

12 December 2020

The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells

1 reference

12 December 2020

Sodium intake and renal responses to captopril in normal man and in essential hypertension

1 reference

12 December 2020

Immune-complex glomerulopathy in patients treated with captopril

1 reference

12 December 2020

Increased Glomerular Filtration Rate after Converting-Enzyme Inhibition in Essential Hypertension

1 reference

12 December 2020

Regulation of renal hemodynamics and glomerular filtration in patients with renovascular hypertension during converting enzyme inhibition with captopril

1 reference

12 December 2020

Randomised controlled trial of enalapril and beta blockers in non-diabetic chronic renal failure

1 reference

12 December 2020

Fatal Pancytopenia Associated with the Use of Captopril

1 reference

12 December 2020

Additive antiproteinuric effect of the NSAID indomethacin and the ACE inhibitor lisinopril

1 reference

12 December 2020

Angiotensin blockade and the progression of renal damage in the spontaneously hypertensive rat

1 reference

12 December 2020

Effects of angiotensin on proximal tubular reabsorption

1 reference

12 December 2020

Moderate sodium restriction in hypertensive subjects: renal effects of ACE-inhibition

1 reference

12 December 2020

Reversibility of captopril-induced renal insufficiency after prolonged use in an unusual case of renovascular hypertension

1 reference

12 December 2020

Renal insufficiency with combinations of angiotensin converting enzyme inhibitors and diuretics.

1 reference

12 December 2020

Interruption of the renin-angiotensin system in hypertensive patients by captopril induces sustained reduction in aldosterone secretion, potassium retention and natruiresis

1 reference

12 December 2020

Contrasting acute effects of captopril and nifedipine on renal function in renovascular hypertension

1 reference

12 December 2020

Cholesterol: a renal risk factor in diabetic nephropathy?

1 reference

12 December 2020

Symptomatic antiproteinuric treatment decreases serum lipoprotein (a) concentration in patients with glomerular proteinuria

1 reference

12 December 2020

Effect of antihypertensive treatment on kidney function in diabetic nephropathy

1 reference

12 December 2020

Plasma aldosterone concentrations in chronic renal disease

1 reference

12 December 2020

Association between angiotensin-converting-enzyme gene polymorphism and failure of renoprotective therapy

1 reference

12 December 2020

Prevention of diabetic renal disease with special reference to microalbuminuria

1 reference

12 December 2020

Captopril-Induced Functional Renal Insufficiency in Patients with Bilateral Renal-Artery Stenoses or Renal-Artery Stenosis in a Solitary Kidney

1 reference

12 December 2020

Randomly allocated study of the effects of standard therapy versus ACE inhibition on micro-albuminuria in essential hypertension

1 reference

12 December 2020

Effect of ANG II receptor antagonist on albuminuria and renal function in passive Heymann nephritis

1 reference

12 December 2020

Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat

1 reference

12 December 2020

Adverse reactions with angiotensin converting enzyme (ACE) inhibitors

1 reference

12 December 2020

Renal scintigraphic captopril test in the diagnosis of renovascular hypertension

1 reference

12 December 2020

Antiproteinuric effect predicts renal protection by angiotensin-converting enzyme inhibition in rats with established adriamycin nephrosis

1 reference

12 December 2020

Functional renal insufficiency during long-term therapy with captopril and enalapril in severe chronic heart failure

1 reference

12 December 2020

Effect of chronic ACE inhibition on the diagnostic value of renography for renovascular hypertension: a preliminary report

1 reference

12 December 2020

Vasoactive agents affect growth and protein synthesis of cultured rat mesangial cells

1 reference

12 December 2020

A short-term antihypertensive treatment-induced fall in glomerular filtration rate predicts long-term stability of renal function

1 reference

12 December 2020

Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction

1 reference

12 December 2020

Angiotensin converting enzyme inhibitor modulates glomerular function and structure by distinct mechanisms

1 reference

12 December 2020

Renal protective effect of enalapril in diabetic nephropathy

1 reference

12 December 2020

Reversible renal insufficiency due to angiotensin converting enzyme inhibitors in hypertensive nephrosclerosis

1 reference

12 December 2020

Role of the deletion of polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy

1 reference

12 December 2020

Short-term antiproteinuric response to antihypertensive treatment predicts long-term GFR decline in patients with non-diabetic renal disease

1 reference

12 December 2020

Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria.

1 reference

12 December 2020

Diagnostic use of angiotensin converting enzyme inhibitors in radioisotope evaluation of unilateral renal artery stenosis

1 reference

12 December 2020

Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells

1 reference

12 December 2020

Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients.

1 reference

12 December 2020

Reduction of proteinuria by angiotensin converting enzyme inhibition

1 reference

12 December 2020

Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. European Microalbuminuria Captopril Study Group

1 reference

12 December 2020

Renal insufficiency due to angiotensin-converting enzyme inhibitors.

1 reference

12 December 2020

Hyperlipidemia and the progression of renal disease

1 reference

12 December 2020

Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril.

1 reference

12 December 2020

Glomerular mesangium. Analysis of the increased activity observed in experimental acute aminonucleoside nephrosis in the rat

1 reference

12 December 2020

Renal renin-angiotensin system in diabetes: functional, immunohistochemical, and molecular biological correlations

1 reference

12 December 2020

Renal protective effects of enalapril in hypertensive NIDDM: role of baseline albuminuria

1 reference

12 December 2020

Renal function in one-kidney, one clip sodium-restricted rats: influence of enalapril and losartan.

1 reference

12 December 2020

Diuretic effects of angiotensin-converting enzyme inhibition: comparison of low and liberal sodium diet in hypertensive patients

1 reference

12 December 2020

Prostaglandins in severe congestive heart failure. Relation to activation of the renin--angiotensin system and hyponatremia

1 reference

12 December 2020

Long-term benefits of the antiproteinuric effect of angiotensin-converting enzyme inhibition in nondiabetic renal disease

1 reference

12 December 2020

Reduction of the antihypertensive effect of captopril induced by prostaglandin synthetase inhibition

1 reference

12 December 2020

Captopril: benefits and risks in severe hypertension

1 reference

12 December 2020

Hyperkalemia in azotemic patients during angiotensin-converting enzyme inhibition and aldosterone reduction with captopril

1 reference

12 December 2020

Pharmacokinetic drug interactions with ACE inhibitors

1 reference

12 December 2020

Use of angiotensin-converting enzyme inhibitors for the preservation of kidney function. A retrospective study

1 reference

12 December 2020

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

12 December 2020

Captopril-induced renal insufficiency and the role of sodium balance

1 reference

12 December 2020

Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells

1 reference

12 December 2020

Choosing the right ACE inhibitor. A guide to selection

1 reference

12 December 2020

Angiotensin receptor antagonists: focus on losartan

1 reference

12 December 2020

Additive antiproteinuric effect of ACE inhibition and a low-protein diet in human renal disease

1 reference

12 December 2020

Comparison of the effects of ACE inhibitors and calcium channel blockers on the progression of renal failure

1 reference

12 December 2020

Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy

1 reference

12 December 2020

An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels

1 reference

12 December 2020

Mechanisms of action of various hormones and vasoactive substances on glomerular ultrafiltration in the rat

1 reference

12 December 2020

ACE inhibition preserves renal function better than beta-blockade in the treatment of essential hypertension

1 reference

12 December 2020

Short and long term effects of antihypertensive therapy in the diabetic rat

1 reference

12 December 2020

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

12 December 2020

Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy

1 reference

12 December 2020

Reversible renal failure associated with angiotensin-converting enzyme inhibitors in polycystic kidney disease

1 reference

12 December 2020

10.2165/00002018-199615030-00005

Identifiers

DOI

1 reference

Dimensions Publication ID

27 September 2017

0 references

1 reference